These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 29589675)
21. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of pseudomyxoma peritonei: A single-center experience. Azzam AZ; Alyahya ZA; Wusaibie AAA; Amin TM Indian J Gastroenterol; 2017 Nov; 36(6):452-458. PubMed ID: 29185227 [TBL] [Abstract][Full Text] [Related]
22. Peritoneal carcinomatosis arising from rectal or colonic adenocarcinoma treated with cytoreductive surgery (CRS) hyperthermic intraperitoneal chemotherapy (HIPEC): two different diseases. Tonello M; Ortega-Perez G; Alonso-Casado O; Torres-Mesa P; Guiñez G; Gonzalez-Moreno S Clin Transl Oncol; 2018 Oct; 20(10):1268-1273. PubMed ID: 29667123 [TBL] [Abstract][Full Text] [Related]
23. Treatment of pseudomyxoma peritonei with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): a single center experience. Robella M; Vaira M; Marsanic P; Mellano A; Cinquegrana A; Sottile A; De Simone M Minerva Chir; 2013 Dec; 68(6):569-77. PubMed ID: 24193289 [TBL] [Abstract][Full Text] [Related]
24. Treatment-Related Mortality After Cytoreductive Surgery and HIPEC in Patients with Colorectal Peritoneal Carcinomatosis is Underestimated by Conventional Parameters. Simkens GA; van Oudheusden TR; Braam HJ; Luyer MD; Wiezer MJ; van Ramshorst B; Nienhuijs SW; de Hingh IH Ann Surg Oncol; 2016 Jan; 23(1):99-105. PubMed ID: 26148758 [TBL] [Abstract][Full Text] [Related]
25. Role of CRS and HIPEC in appendiceal and colorectal malignancies: Indian experience. Gupta N; Asif S; Gandhi J; Rajpurohit S; Singh S Indian J Gastroenterol; 2017 Mar; 36(2):126-130. PubMed ID: 28393331 [TBL] [Abstract][Full Text] [Related]
26. Early recurrence after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Tan GHC; Chia CS; Tan SH; Soo KC; Teo MCC Int J Clin Oncol; 2018 Oct; 23(5):989-998. PubMed ID: 29869757 [TBL] [Abstract][Full Text] [Related]
27. Survival after complete cytoreductive surgery and HIPEC for extensive pseudomyxoma peritonei. Benhaim L; Faron M; Gelli M; Sourrouille I; Honoré C; Delhorme JB; Elias D; Goere D Surg Oncol; 2019 Jun; 29():78-83. PubMed ID: 31196498 [TBL] [Abstract][Full Text] [Related]
28. Preoperative Thrombocytosis Predicts Shortened Survival in Patients with Malignant Peritoneal Mesothelioma Undergoing Operative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy. Li YC; Khashab T; Terhune J; Eckert RL; Hanna N; Burke A; Richard Alexander H Ann Surg Oncol; 2017 Aug; 24(8):2259-2265. PubMed ID: 28324285 [TBL] [Abstract][Full Text] [Related]
29. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for managing peritoneal carcinomatosis from endometrial carcinoma: a single-center experience of 6 cases. Abu-Zaid A; Azzam AZ; AlOmar O; Salem H; Amin T; Al-Badawi IA Ann Saudi Med; 2014; 34(2):159-66. PubMed ID: 24894786 [TBL] [Abstract][Full Text] [Related]
30. Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: Long-term outcomes and perspectives from a high-volume center. Muñoz-Casares FC; Medina-Fernández FJ; Arjona-Sánchez Á; Casado-Adam Á; Sánchez-Hidalgo JM; Rubio MJ; Ortega-Salas R; Muñoz-Villanueva MC; Rufián-Peña S; Briceño FJ Eur J Surg Oncol; 2016 Feb; 42(2):224-33. PubMed ID: 26673283 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of cytoreductive surgery and HIPEC for peritoneal surface malignancies: analysis of 384 consecutive cases. Narasimhan V; Das A; Warrier S; Lynch C; McCormick J; Tie J; Michael M; Ramsay R; Heriot A Langenbecks Arch Surg; 2019 Aug; 404(5):527-539. PubMed ID: 31377856 [TBL] [Abstract][Full Text] [Related]
32. Morbidity, mortality, and oncological outcomes of 401 consecutive cytoreductive procedures with hyperthermic intraperitoneal chemotherapy (HIPEC). Desantis M; Bernard JL; Casanova V; Cegarra-Escolano M; Benizri E; Rahili AM; Benchimol D; Bereder JM Langenbecks Arch Surg; 2015 Jan; 400(1):37-48. PubMed ID: 25319432 [TBL] [Abstract][Full Text] [Related]
33. Perioperative Morbidity of Gastrectomy During CRS-HIPEC: An ACS-NSQIP Analysis. Paredes AZ; Guzman-Pruneda FA; Abdel-Misih S; Hays J; Dillhoff ME; Pawlik TM; Cloyd JM J Surg Res; 2019 Sep; 241():31-39. PubMed ID: 31004870 [TBL] [Abstract][Full Text] [Related]
34. Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results. Golse N; Bakrin N; Passot G; Mohamed F; Vaudoyer D; Gilly FN; Glehen O; Cotte E J Surg Oncol; 2012 Aug; 106(2):197-203. PubMed ID: 22331814 [TBL] [Abstract][Full Text] [Related]
35. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504 [TBL] [Abstract][Full Text] [Related]
36. Diffuse malignant peritoneal mesothelioma: Evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE Database: Multi-Institutional Retrospective Study. Kepenekian V; Elias D; Passot G; Mery E; Goere D; Delroeux D; Quenet F; Ferron G; Pezet D; Guilloit JM; Meeus P; Pocard M; Bereder JM; Abboud K; Arvieux C; Brigand C; Marchal F; Classe JM; Lorimier G; De Chaisemartin C; Guyon F; Mariani P; Ortega-Deballon P; Isaac S; Maurice C; Gilly FN; Glehen O; Eur J Cancer; 2016 Sep; 65():69-79. PubMed ID: 27472649 [TBL] [Abstract][Full Text] [Related]
37. Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis. Vassos N; Förtsch T; Aladashvili A; Hohenberger W; Croner RS World J Surg Oncol; 2016 Feb; 14(1):42. PubMed ID: 26912149 [TBL] [Abstract][Full Text] [Related]
38. More Synchronous Peritoneal Disease but Longer Survival in Younger Patients with Carcinomatosis from Colorectal Cancer Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Solomon D; DeNicola NL; Feferman Y; Bekhor E; Reppucci ML; Feingold D; Aycart SN; Magge DR; Golas BJ; Labow DM; Sarpel U Ann Surg Oncol; 2019 Mar; 26(3):845-851. PubMed ID: 30643994 [TBL] [Abstract][Full Text] [Related]
39. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies. Wu HT; Yang XJ; Huang CQ; Sun JH; Ji ZH; Peng KW; Zhang Q; Li Y World J Surg Oncol; 2016 Sep; 14(1):246. PubMed ID: 27633880 [TBL] [Abstract][Full Text] [Related]
40. Peritoneal carcinomatosis from unusual cancer origins: Is there a role for hyperthermic intraperitoneal chemotherapy? Honoré C; Goéré D; Macovei R; Colace L; Benhaim L; Elias D J Visc Surg; 2016 Apr; 153(2):101-7. PubMed ID: 26698380 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]